Market Overview:
The global antipyretic analgesic active pharmaceutical ingredients (API) market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of pain and fever, rising demand for over-the-counter drugs, and growing geriatric population. Based on type, the global antipyretic analgesic API market is segmented into paracetamol, aspirin, ibuprofen, naproxen, diclofenac sodium salt (diclofenac), oxaprozin sodium salt (oxaprozin), dexibuprofen hydrate (dexibuprofen), and others. Paracetamol is expected to dominate the market in terms of revenue share during the forecast period owing to its high usage rates across various applications such as headache and fever reliefs; cold and cough reliefs; muscle cramps; postoperative pain reliefs; dysmenorrhea reliefs among others. Ibuprofen is also anticipated to witness significant growth during the forecast period due its high usage rates for treating various indications such as headaches & migraines; dental pain & inflammation after tooth extraction surgery; menstrual cramps among others.
Product Definition:
An antipyretic analgesic active pharmaceutical ingredient is a drug that is used to reduce fever and relieve pain. These drugs are important because they help to make patients more comfortable and can speed up the healing process.
Paracetamol:
Paracetamol, also known as acetaminophen or APAP is a widely used over the counter drug in fever reduction and pain management. It is generally available without a prescription in both solid (capsules) and liquid (tablets & syrup) forms. Paracetamol has been studied extensively for its effect on feverish illnesses such as malaria, typhoid, dengue hemorrhagic fever, hepatitis C and HIV-1 infection.
Aspirin:
Aspirin is a drug used to treat pain. It works by decreasing the activity of cyclo-oxygenase, which causes pain. Aspirin is available in various forms such as tablets, powders, and liquids that are used for the treatment of different types of pain including muscle ache or arthritis and fever.
Application Insights:
The application segment includes headache and fever, cold and cough, muscle cramps, others. The headache and fever segment dominated the global market in terms of revenue in 2017 owing to increasing prevalence of this condition. According to a study published by the CDC in 2014, it was estimated that around 30% of adults experienced migraine headaches every year. Also according to WHO migraine Fact Sheet 2018, migraine is one of the most common diseases worldwide with an incidence rate varying from country to country between 0.3% and 15%. Around 50 million people are estimated to be suffering from migraines globally which is expected to increase due largelyto population growth along with rising awareness regarding prevention measures taken against this disease coupled with availabilityof effective treatment options such as analgesic drugs that address symptoms such as pain relief without causing drowsiness or other adverse effects thereby driving demand for antipyretic analgesic active pharmaceutical ingredients over the forecast period.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is anticipated to maintain its position during the forecast period. The region accounts for a major share of global consumption due to high population density, rising disposable income levels, and increasing healthcare spending. China is projected to be one of the key markets in Asia Pacific over the forecast period owing to rapid economic growth coupled with an increase in per capita healthcare expenditure.
The presence of a large number of local manufacturers has resulted in low prices for consumers as well as producers across this region. In addition, easy access to raw materials through imports from other regions has contributed significantly towards maintaining production levels at lower costs than those prevailing globally thus benefitting end-use industries such as medicine manufacturing companies across this region tremendously.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases are responsible for around 63% of all deaths worldwide. This number is expected to increase to 73% by 2030. The growing prevalence of chronic diseases will lead to an increase in demand for antipyretic analgesics in the coming years.
- Rising awareness about pain relief medications: There has been a significant rise in awareness about pain relief medications in recent years, especially among women and elderly people. This has led to an increase in demand for antipyretic analgesics globally.
- Technological advancements: The pharmaceutical industry is constantly evolving with new technological advancements being made every day. These advancements have led to the development of novel antipyretic analgesics that are more effective and safer than traditional ones available on the market today .This will lead to an increase in demand for these drugs in the coming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Antipyretic Analgesic Active Pharmaceutical Ingredients Market Research Report
By Type
Paracetamol, Aspirin, Ibuprofen, Naproxen, Diclofenac, Oxaprozin, Dexibuprofen, Others
By Application
Headache and Fever, Cold and Cough, Muscle Cramps, Others
By Companies
Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm, Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Jingye Group, Hunan Zhongnan Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market Report Segments:
The global Antipyretic Analgesic Active Pharmaceutical Ingredients market is segmented on the basis of:
Types
Paracetamol, Aspirin, Ibuprofen, Naproxen, Diclofenac, Oxaprozin, Dexibuprofen, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Headache and Fever, Cold and Cough, Muscle Cramps, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mallinckrodt Pharmaceuticals
- IOL
- Anqiu Lu'an Pharmaceutical
- Novacyl
- BASF
- Anhui BBCA Pharmaceuticals
- Hubei Biocause
- Xinhua Pharm
- Granules India Limited
- Huagang Pharm
- Hebei Jiheng Pharmaceutical
- Zhejiang Kangle Pharmaceutical
- Jingye Group
- Hunan Zhongnan Pharmaceutical
Highlights of The Antipyretic Analgesic Active Pharmaceutical Ingredients Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Paracetamol
- Aspirin
- Ibuprofen
- Naproxen
- Diclofenac
- Oxaprozin
- Dexibuprofen
- Others
- By Application:
- Headache and Fever
- Cold and Cough
- Muscle Cramps
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antipyretic Analgesic Active Pharmaceutical Ingredients Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antipyretic analgesics are medications that reduce fever. They are used to treat a variety of conditions, including the common cold and flu. Antipyretics work by reducing inflammation and pain in the body.
Some of the major companies in the antipyretic analgesic active pharmaceutical ingredients market are Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm, Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Jingye Group, Hunan Zhongnan Pharmaceutical.
The antipyretic analgesic active pharmaceutical ingredients market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antipyretic Analgesic Active Pharmaceutical Ingredients Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antipyretic Analgesic Active Pharmaceutical Ingredients Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antipyretic Analgesic Active Pharmaceutical Ingredients Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antipyretic Analgesic Active Pharmaceutical Ingredients Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size & Forecast, 2018-2028
4.5.1 Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size and Y-o-Y Growth
4.5.2 Antipyretic Analgesic Active Pharmaceutical Ingredients Market Absolute $ Opportunity
Chapter 5 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Type
5.2.1 Paracetamol
5.2.2 Aspirin
5.2.3 Ibuprofen
5.2.4 Naproxen
5.2.5 Diclofenac
5.2.6 Oxaprozin
5.2.7 Dexibuprofen
5.2.8 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Applications
6.2.1 Headache and Fever
6.2.2 Cold and Cough
6.2.3 Muscle Cramps
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antipyretic Analgesic Active Pharmaceutical Ingredients Analysis and Forecast
9.1 Introduction
9.2 North America Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Type
9.6.1 Paracetamol
9.6.2 Aspirin
9.6.3 Ibuprofen
9.6.4 Naproxen
9.6.5 Diclofenac
9.6.6 Oxaprozin
9.6.7 Dexibuprofen
9.6.8 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Applications
9.10.1 Headache and Fever
9.10.2 Cold and Cough
9.10.3 Muscle Cramps
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Analysis and Forecast
10.1 Introduction
10.2 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Type
10.6.1 Paracetamol
10.6.2 Aspirin
10.6.3 Ibuprofen
10.6.4 Naproxen
10.6.5 Diclofenac
10.6.6 Oxaprozin
10.6.7 Dexibuprofen
10.6.8 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Applications
10.10.1 Headache and Fever
10.10.2 Cold and Cough
10.10.3 Muscle Cramps
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antipyretic Analgesic Active Pharmaceutical Ingredients Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Type
11.6.1 Paracetamol
11.6.2 Aspirin
11.6.3 Ibuprofen
11.6.4 Naproxen
11.6.5 Diclofenac
11.6.6 Oxaprozin
11.6.7 Dexibuprofen
11.6.8 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Applications
11.10.1 Headache and Fever
11.10.2 Cold and Cough
11.10.3 Muscle Cramps
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antipyretic Analgesic Active Pharmaceutical Ingredients Analysis and Forecast
12.1 Introduction
12.2 Latin America Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Type
12.6.1 Paracetamol
12.6.2 Aspirin
12.6.3 Ibuprofen
12.6.4 Naproxen
12.6.5 Diclofenac
12.6.6 Oxaprozin
12.6.7 Dexibuprofen
12.6.8 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Applications
12.10.1 Headache and Fever
12.10.2 Cold and Cough
12.10.3 Muscle Cramps
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antipyretic Analgesic Active Pharmaceutical Ingredients Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Type
13.6.1 Paracetamol
13.6.2 Aspirin
13.6.3 Ibuprofen
13.6.4 Naproxen
13.6.5 Diclofenac
13.6.6 Oxaprozin
13.6.7 Dexibuprofen
13.6.8 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antipyretic Analgesic Active Pharmaceutical Ingredients Market Size Forecast by Applications
13.10.1 Headache and Fever
13.10.2 Cold and Cough
13.10.3 Muscle Cramps
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antipyretic Analgesic Active Pharmaceutical Ingredients Market: Competitive Dashboard
14.2 Global Antipyretic Analgesic Active Pharmaceutical Ingredients Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mallinckrodt Pharmaceuticals
14.3.2 IOL
14.3.3 Anqiu Lu'an Pharmaceutical
14.3.4 Novacyl
14.3.5 BASF
14.3.6 Anhui BBCA Pharmaceuticals
14.3.7 Hubei Biocause
14.3.8 Xinhua Pharm
14.3.9 Granules India Limited
14.3.10 Huagang Pharm
14.3.11 Hebei Jiheng Pharmaceutical
14.3.12 Zhejiang Kangle Pharmaceutical
14.3.13 Jingye Group
14.3.14 Hunan Zhongnan Pharmaceutical
